The Sackler family and Purdue Pharma, maker of OxyContin, have increased their settlement offer to $7.4 billion amid ongoing legal negotiations with states, tribes and local governments that sued Purdue for creating and fueling the deadly opioid epidemic. Under the new deal, Sackler family members would not receive immunity from future opioid lawsuits — a condition they previously insisted on but was rejected by the Supreme Court in June. Instead, a portion of the settlement money will be set aside to cover the cost of any future litigation against the Sacklers. All the states, cities, counties and territories involved in the case must agree to the terms of the new deal before it can move forward.